-
Mashup Score: 0Overcoming the blood–brain barrier by Annexin A1-binding peptide to target brain tumours - 4 year(s) ago
Annexin A1 is expressed specifically on the tumour vasculature surface. Intravenously injected IF7 targets tumour vasculature via annexin A1. We tested the hypothesis that IF7 overcomes the blood–brain barrier and that the intravenously injected IF7C(RR)-SN38 eradicates brain tumours in the mouse. (1) A dual-tumour model was generated by inoculating luciferase-expressing melanoma B16 cell line,…
Source: British Journal of CancerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Interventions to reduce the time to diagnosis of brain tumours - Grant, R - 2020 | Cochrane Library - 4 year(s) ago
Cochrane Database of Systematic Reviews Collapse all Expand all Background Brain tumours are recognised as one of the most difficult cancers to diagnose because presenting symptoms, such as headache, cognitive symptoms, and seizures, may be more commonly attributable to other, more benign conditions. Interventions to reduce the time to diagnosis of brain tumours include national…
Source: www.cochranelibrary.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Primary Brain Tumours in the Era of COVID-19 - 4 year(s) ago
Designed to offer an expert opinion exchange and provide some practical approaches for management of primary brain tumours during COVID-19 pandemic
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Researchers from @SBPdiscovery and Yakult Central Institute have developed a new technique to deliver cancer drugs directly to #braintumours Check out the research here: https://t.co/aDAjLYEqSt https://t.co/LXfHlgsJrB